Strikingly, Mettl3-mediated m6A modification destabilized Smad3 mRNA via Ythdf2-dependent recognition of a specific m6A site (position 4591) in the 3’UTR, accounting for impaired tumor MDSC maturation. The gene discussed is YTHDF2; the disease is neoplasm.